Immunotech Laboratories Stock Market Value
| IMMB Stock | USD 0.0002 0.0001 100.00% |
| Symbol | Immunotech |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunotech Laboratories. Market participants price Immunotech higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Immunotech Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.59) |
Immunotech Laboratories's market price often diverges from its book value, the accounting figure shown on Immunotech's balance sheet. Smart investors calculate Immunotech Laboratories' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Immunotech Laboratories' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Immunotech Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunotech Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunotech Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immunotech Laboratories 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunotech Laboratories' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunotech Laboratories.
| 12/02/2025 |
| 03/02/2026 |
If you would invest 0.00 in Immunotech Laboratories on December 2, 2025 and sell it all today you would earn a total of 0.00 from holding Immunotech Laboratories or generate 0.0% return on investment in Immunotech Laboratories over 90 days. Immunotech Laboratories is related to or competes with Adagene, Alto Neuroscience, Aspire BioPharma, Biostem Technologies, Can Fite, Cognition Therapeutics, and Mirum Pharmaceuticals. Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficienc... More
Immunotech Laboratories Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunotech Laboratories' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunotech Laboratories upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1158 | |||
| Maximum Drawdown | 100.0 |
Immunotech Laboratories Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunotech Laboratories' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunotech Laboratories' standard deviation. In reality, there are many statistical measures that can use Immunotech Laboratories historical prices to predict the future Immunotech Laboratories' volatility.| Risk Adjusted Performance | 0.1036 | |||
| Jensen Alpha | 1.47 | |||
| Total Risk Alpha | 0.2202 | |||
| Treynor Ratio | 3.34 |
Immunotech Laboratories March 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1036 | |||
| Market Risk Adjusted Performance | 3.35 | |||
| Mean Deviation | 2.98 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 12.31 | |||
| Variance | 151.52 | |||
| Information Ratio | 0.1158 | |||
| Jensen Alpha | 1.47 | |||
| Total Risk Alpha | 0.2202 | |||
| Treynor Ratio | 3.34 | |||
| Maximum Drawdown | 100.0 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Immunotech Laboratories Backtested Returns
Immunotech Laboratories is out of control given 3 months investment horizon. Immunotech Laboratories holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13 % return per unit of risk over the last 3 months. We have collected data for nineteen different technical indicators, which can help you to evaluate if expected returns of 1.59% are justified by taking the suggested risk. Use Immunotech Laboratories Risk Adjusted Performance of 0.1036, standard deviation of 12.31, and Market Risk Adjusted Performance of 3.35 to evaluate company specific risk that cannot be diversified away. Immunotech Laboratories holds a performance score of 10 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.45, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Immunotech Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding Immunotech Laboratories is expected to be smaller as well. Use Immunotech Laboratories total risk alpha, as well as the relationship between the daily balance of power and day typical price , to analyze future returns on Immunotech Laboratories.
Auto-correlation | 0.00 |
No correlation between past and present
Immunotech Laboratories has no correlation between past and present. Overlapping area represents the amount of predictability between Immunotech Laboratories time series from 2nd of December 2025 to 16th of January 2026 and 16th of January 2026 to 2nd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunotech Laboratories price movement. The serial correlation of 0.0 indicates that just 0.0% of current Immunotech Laboratories price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Immunotech Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunotech Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunotech Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunotech Laboratories Stock:Check out Immunotech Laboratories Correlation, Immunotech Laboratories Volatility and Immunotech Laboratories Performance module to complement your research on Immunotech Laboratories. For information on how to trade Immunotech Stock refer to our How to Trade Immunotech Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Immunotech Laboratories technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.